Investment Research Radio

Investment Research Radio
  • 0.0 (0)
  • Investing
  • Semiweekly

Investment Research Radio interviews the most compelling emerging companies across the public and private markets... from seed stage ventures through TSXV and Nasdaq listed companies. Sector agnostic by design, the show focuses on innovative businesses, disruptive technologies and the major trends shaping industries and markets around the world.

  1. 1d ago

    Nanochon With CEO Dr. Ben Holmes

    Nanochon with CEO Dr. Ben Holmes | 3D-Printed Implants and the Future of Cartilage Repair In this episode of Investment Research Radio, Ray Crowley sits down with Dr. Ben Holmes, Co-Founder and CEO of Nanochon, a medical technology company developing next generation orthopedic implants designed to repair damaged cartilage and potentially offer an alternative to more invasive joint replacement procedures. Nanochon is developing Chondrograft, a synthetic, 3D printed implant designed to restore cartilage function in patients suffering from focal cartilage defects and early-stage osteoarthritis. Using proprietary biomaterials and advanced manufacturing techniques, the technology aims to address a significant gap in orthopedic care, particularly for younger and active patients who may not be ideal candidates for total knee replacement. Dr. Holmes discusses the origins of Nanochon, the science behind its implant technology, and the journey from university research and biomedical engineering to clinical development and commercialization. We explore the company's preclinical research, including animal studies, its progression into first-in-human clinical trials, and the regulatory and clinical milestones required to bring an innovative orthopedic implant to market. We also discuss the broader market opportunity for cartilage repair, the challenges of building and financing a medical device company, and Nanochon's longer-term vision for expanding its technology across additional joints and orthopedic applications. Topics covered include: The founding story behind Nanochon and the origins of its technology. Chondrograft™ and the science of synthetic, 3D-printed cartilage implants. Biomaterials, advanced manufacturing, and tissue integration. Preclinical research and animal study results. First-in-human clinical development and regulatory milestones. The limitations of existing cartilage repair treatments. The commercial opportunity in orthopedic implants and joint preservation. Fundraising, commercialization, and the future of Nanochon. Learn more about Nanochon: https://nanochon.com/ Guest: Dr. Ben Holmes, Co-Founder and CEO, Nanochon Host: Ray Crowley, Investment Research Radio

  2. 5d ago

    LifePlus with CEO Alodeep Sanyal

    LifePlus: LifeLeaf Watch, Non-Invasive Health Monitoring and the Future of Wearables In this episode of Investment Research Radio, we explore LifePlus and its upcoming LifeLeaf smartwatch, a wearable designed to provide blood sugar and blood pressure trends from the wrist without needles or a traditional blood pressure cuff. LifePlus combines optical sensing, signal processing, and artificial intelligence to interpret physiological signals throughout everyday life. Its clinical research includes studies involving more than 70,000 paired readings across seven clinical sites, with findings published in peer reviewed journals including Diabetes, Diabetes Technology & Therapeutics, and the Journal of Hypertension. The company's research has also been presented at major scientific meetings, including the American Diabetes Association and the American Heart Association. We discuss the science behind LifeLeaf, the challenges of non invasive physiological monitoring, and how LifePlus is translating years of research and development into a consumer wearable. With its planned retail launch and Kickstarter campaign fast approaching, we also explore the company's commercialization strategy, distribution opportunities, and the potential for wearable technology to give consumers greater insight into how daily habits affect their health. Learn more: https://www.lifeplus.ai/

  3. Oct 28

    Nutromics With CEO Peter Vranes

    Investment Research Radio: Nutromics — Precision Antibiotic Dosing and the Future of Wearable Biosensing In this episode of Investment Research Radio, we explore Nutromics and its innovative wearable microneedle technology designed to transform precision medicine and continuous molecular monitoring. Nutromics' first product focuses on vancomycin, a powerful antibiotic widely used in hospitals to treat serious infections, including MRSA and sepsis. Because vancomycin has a narrow therapeutic window, clinicians must carefully balance effective dosing against the risk of toxicity, including kidney injury. Nutromics is developing a wearable sensor that continuously measures drug concentrations in the fluid beneath the skin, potentially helping clinicians make faster, more informed dosing decisions while reducing reliance on repeated blood draws. We discuss the clinical development underway, the potential benefits for hospital workflows and patient care, and the significance of the FDA granting the company's Vancomycin Therapeutic Drug Monitoring Patch Breakthrough Device Designation in September 2026. The designation supports regulatory engagement but does not constitute FDA marketing approval. Beyond antibiotic dosing, we explore Nutromics' longer-term vision for its Lab-on-a-Patch technology: wearable microneedle sensors capable of measuring multiple drugs and biomarkers simultaneously. Future applications could include monitoring indicators associated with sepsis, kidney injury, inflammation, and cardiovascular disease. Join us for a conversation about precision dosing, clinical innovation, and the potential for continuous, multi-analyte biosensing to change how hospitals monitor patients and manage treatment. Learn more: https://www.nutromics.com/

  4. Oct 26

    Purecore Metals With CEO Peter Berdusco

    Purecore Metals: A New Critical Minerals Story | Peter Berdusco, Founder & CEO In this five-minute episode of Investment Research Radio, I sit down with Peter Berdusco, Founder and CEO of Purecore Metals, a newly listed Canadian mining junior trading on the Canadian Securities Exchange (CSE: PURE), the OTCQB (OTCQB: PPURF) and the Frankfurt Stock Exchange (FSE: J8Y). Peter shares the story behind Purecore's inception, its focus on critical minerals including uranium and copper, and its exploration properties in Saskatchewan and British Columbia. We discuss the company's early development as a public company and its opportunity to participate in growing demand for nuclear energy, electrification and critical mineral supply. This is the first in a planned series of short, five minute conversations with founders and executives building emerging companies. Learn more: https://purecoremetals.com/

  5. Oct 22

    Skuvent With CEO Maunark Patel

    In this episode of Investment Research Radio, Ray Crowley speaks with Maunark Patel, Co-Founder and CEO of Skuvent, about the operational challenges medical device manufacturers face managing inventory, implants, and surgical equipment across warehouses, sales representatives, hospitals, and operating rooms. The conversation explores how Skuvent is addressing gaps in medical device field operations, including inventory tracking, consignment management, surgical case coordination, product transfers, expiration monitoring, audits, and integration with existing ERP and CRM systems. Maunark shares the story behind Skuvent, the problems the company aims to solve for medical device manufacturers, and the broader opportunity to improve visibility, accountability, and efficiency across complex medical device supply chains. We also discuss the competitive landscape, commercialization strategy, and Maunark's vision for the company's future. Join us for a conversation about the business of medical technology, the operational challenges facing device manufacturers, and the opportunity to modernize how medical devices move from the warehouse to the point of care. https://www.skuvent.com

  6. Oct 19

    Persperion with CEO Dr. Lu Yin

    What if glucose monitoring could be done without needles, using sweat sensing technology instead? In this episode of Investment Research Radio, I speak with Lu Yin, CEO and Co-Founder of Persperion, a company developing finger touch based sweat sensing technology with an initial focus on non-invasive glucose monitoring. We discuss the science behind Persperion's approach, the challenges of developing accurate non-invasive biosensors, and the potential to make health monitoring more accessible and convenient. We also explore the broader opportunity for sweat-based diagnostics and how advances in sensing technology could open the door to monitoring additional biomarkers in the future. As Persperion advances its technology toward clinical validation and commercialization, we discuss the development milestones, regulatory considerations, and market opportunities involved in bringing a new medical technology to patients. Tune in to hear Lu's perspective on building a deep technology company and the future of non invasive diagnostics. https://persperion.com/

  7. Oct 15

    WearbleDose with CEO John Sanwo

    In this episode of Investment Research Radio, Ray Crowley speaks with John Sanwo, Founder and CEO of WearableDose, about the company's development of precision radiation detection technology. WearableDose is developing wearable radiation sensing technology designed to support radiation monitoring and safety across applications such as healthcare, oncology, defense, aerospace and other environments where radiation exposure is a concern. Ray and John discuss the technology behind WearableDose, the challenges of developing wearable radiation detection systems, potential applications across different industries, and the company's journey toward commercialization. The conversation explores the growing role of advanced sensing technologies in improving radiation awareness, monitoring and safety for people working in environments where exposure matters. Tune in to learn more about WearableDose, its technology and John's vision for the future of wearable radiation detection. https://wearabledose.com/

  8. Oct 13

    NeuroDyne with CEO Dr. Mark Myers

    NeuroDyne with CEO Dr. Mark Myers | Investment Research Radio In this episode of Investment Research Radio, Ray Crowley speaks with Dr. Mark Myers, CEO and CTO of NeuroDyne, about the company's work in wearable electroencephalography (EEG) technology and its development of a wearable EEG cap designed to measure brain activity. Dr. Myers discusses the technology behind NeuroDyne's approach, its potential applications in neurological monitoring and healthcare, and the company's progress toward FDA Class II clearance. We explore the challenges of bringing innovative neurotechnology to market, the potential for future product iterations and applications, and the opportunities for wearable brain monitoring as neuroscience and medical technology continue to advance. Tune in to learn more about NeuroDyne's technology, its development journey, and Dr. Myers' vision for the future of wearable EEG.   https://www.neurodyneinc.com/

See All (63)

About

Investment Research Radio interviews the most compelling emerging companies across the public and private markets... from seed stage ventures through TSXV and Nasdaq listed companies. Sector agnostic by design, the show focuses on innovative businesses, disruptive technologies and the major trends shaping industries and markets around the world.

Information